Intake of dissolved organic matter from deep seawater inhibits atherosclerosis progression by Radhakrishnan, Geethalakshmi et al.
Intake of dissolved organic matter from deep seawater inhibits atherosclerosis 
progression 
 
Geethalakshmi Radhakrishnana, Morio Yamamotoa, Hironori Maedaa, Aimi Nakagawaa, 
Rajesh Katare Gopalraoa, Hironobu Okadaa, Hideaki Nishimoria, Seiichiro Wariishia, 
Eiji Todab, Hiroshi Ogawac, Shiro Sasaguria.  
 
aDept. of Surgery II, Faculty of Medicine, Kochi University, Japan  
bSumiko Techno Research, Co. Ltd., Ehime, Japan,  
cOcean Research Institute, The University of Tokyo, Tokyo, Japan. 
 
Corresponding author:  Prof. Shiro Sasaguri, MD, PhD. 
Contact information:   Phone:  +81-88-880-2375, Fax:  +81-88-880-2376 
E-mail: sasaguri@kochi-u.ac.jp 
 
 
 
 
Abstract: 
Dissolved organic matter (DOM) in seawater can be defined as the fraction of organic 
matter that passes through a filter of sub micron pore size. In this study, we have 
examined the effect of DOM of deep seawater (DSW) from Pacific Ocean on platelet 
aggregation and atherosclerosis progression. DSW was passed through a series of filters 
and then through an Octadecyl C18 filter; the retained substance in ethanol was 
designated as C18 extractable DOM (C18-DOM). Our studies showed that C18-DOM 
treatment inhibited platelet aggregation, P-selectin expression and activity of COX-1 
significantly. C18-DOM increased the expression of anti-atherogenic molecule namely 
heme oxygenase-1 in endothelial cells and all these data showed that C18-DOM is 
exhibiting aspirin-like effects. Moreover our in vivo studies showed that C18-DOM 
feeding slowed remarkably the progression of atherosclerosis. Our study demonstrated a 
novel biological effect of oceanic DOM, which has several important implications, 
including a possible therapeutic strategy for atherosclerosis. 
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Atherosclerosis is a progressive disease of arteries, characterized by accumulation 
of lipids and fibrous elements and is responsible for up to 50% of deaths in the modern 
society [1].  
In the history of drug discovery, so far terrestrial resources have been targeted 
which led to the creation of various medicines. Recently, the trend has been switched on 
to the oceans, which is considered as a potential source for the next generation of drugs. 
Chemical compounds extracted from marine organisms such as fungi, sponges have 
been reported to possess anti-cancer, anti-fungal effect, etc [2], [3], [4] and [5].  
In this study we have focussed on the dissolved organic matter (DOM) from 
deep seawater (DSW). DSW was collected from depths beyond 374 meters off 
(mesopelagic zone) the Cape of Muroto, facing the north-east Pacific Ocean, (Latitude 
33.5º N and Longitude 134.10º E) using a DSW-drawing system, where intense up 
welling of DSW occurs due to the movement of ocean currents. Surface seawater was 
also collected from depth 5 meters off at the same location. The purpose of this research 
is to examine the effect and the mechanism of action of DOM in DSW on the 
progression of atherosclerosis.  
Materials and methods 
Preparation of dissolved organic matter. We isolated DOM using a solid phase 
extraction method in which 1500 l of original SW was passed through a series of filters 
of size 50, 5 and 0.2 µm pore sizes, respectively (Y. S. Filter Japan) and then through an 
3M EmporeTM Octadecyl (C18) FF disc (90 mm) to retain the organic substance. The 
filtered DOM was dissolved in 25 ml of ethanol and was designated as C18-DOM. To 
prepare desalinated DSW, original DSW was passed through 50, 5µm filters, and then 
desalinated twice by a reverse osmosis membrane module using HR3155PI (Element 
Configuration: Hollow fiber, single open-ended) in a desalination plant. 1% DSW (v/v) 
was prepared by diluting original DSW with desalinated DSW to a concentration 
approximately 1% of that of original concentration. 1% DSW (v/v) was passed through 
3M EmporeTM Octadecyl (C18) FF disc (90 mm) to remove remnants of organic matter 
and the filtrate is designated Inorganic deep seawater (Inorg-DSW). 
 
Rabbit balloon injury model. Japanese Male White Rabbits (JMWRs) weighing 3-3.2 kg 
(Japan SLC, Inc., Shizuoka, Japan) were used in this study. All animal experimental 
protocols were followed in accordance with the Guide for the Care and Use of 
Laboratory Animals published by the US National Institutes of Health (NIH Publication 
No. 85-23. revised 1996) and the guidelines of our university. Anesthesia was achieved 
by inhalation of 1.39% isofluorane with ketamine hydrochloride (20 mg/kg) and 
Pentobarbital Sodium (50 mg/kg) as pre-anesthetic medication. Balloon injury was 
performed in RCCA as described [13]. Following which the rabbits were divided into 5 
groups. Group a, b, c, d were fed with 50 ml of either distilled water, surface seawater, 
Inorg-DSW, 1% DSW (v/v) per day respectively. The C18-DOM group (e) were fed 200 
µl of C18-DOM dissolved in 50 ml of distilled water once a week. All the groups were 
fed a 1% high cholesterol diet for 4 weeks. After 4 weeks the animals were sacrificed, 
right common carotid artery (RCCA) was harvested, and Van Gieson elastic staining 
was performed in paraffin sections to evaluate the neointimal thickness. 
 
Platelet aggregation. JMWRs were divided into 3 groups. In Group a, rabbits were fed 
with 200 µl of C18-DOM dissolved in 50 ml of distilled water/week. In Group b & c 
were fed with 50 ml/day of 1% DSW (v/v) & 50 ml/day of Inorg DSW respectively. 
Platelets were stimulated by 10 or 40 µM of ADP and 0.2 µg/ml of collagen. Platelet 
aggregations were measured as a change in light transmittance at the start of the 
experiment, 1-week, 2 weeks after feeding [14]. 
 
Cholesterol measurement. JMWRs were divided into 3 groups. In Control gp. rabbits 
were fed with 50 ml/day of distilled water. In 1% DSW (v/v) gp., rabbits were fed with 
50 ml/day of 1% DSW (v/v). In C18-DOM gp., rabbits were fed with 200 µl of 
C18-DOM dissolved in 50 ml of distilled water/week. Rabbits were fed with 1% high 
cholesterol diet for 3 months. Serum samples were collected at the start and end of the 
experiment. 
 
Flow cytometry. To quantify the P-selectin (platelet adhesion molecule) expression, 
platelets were isolated from human blood by centrifugation method as described in 
literature [15]. Ethanol in C18-DOM was evaporated in an automatic environmental 
speed vac system (Savant, Instruments, Inc. Farmingdale, NY) then reconstituted in an 
equal volume of distilled water containing 5% of ethanol. 2x105 platelets in 200 µL of 
buffer were pre-incubated either with 1 mM of aspirin or 50, 500, 5000 times dilution of 
C18-DOM for 15 mins. Then followed by stimulation with 20 µM of ADP for 10 mins 
at 37°C. The platelets were suspended in FAC staining buffer (1x PBS containing 0.05% 
sodium azide and 3% BSA) and then reacted with FITC-labelled mouse anti-human 
CD62P at recommended dilution (BD Pharmingen) for 30 mins in dark. The platelets 
were then washed, and analyzed by flow cytometry (FACScan; Becton Dickinson, San 
Jose, CA.). Non-specific fluorescence was assessed by substitution of the mouse IgG1 k 
Isotype control. 
 
Cyclooxygenase-1 assay. Inhibitory activity of C18-DOM on COX-1 was assayed by 
the use of colorimetric COX (ovine) Inhibitor Screening Assay Kit (Cayman, No. 
560131) according to the protocol recommended by the supplier [16]. The assay was 
performed in triplicate and repeated at three times. 100 µM of aspirin was used as a 
reference. Ethanol in 100 µl of C18-DOM was evaporated in an automatic 
environmental speed vac system (Savant, Instruments, Inc. Farmingdale, NY) then 
reconstituted in an equal volume of distilled water. C18-DOM was added to the reaction 
mixture with various dilutions of 50, 500, 5000 times that of original volume of 
C18-DOM.  
 
Western blotting. Ethanol in C18-DOM was evaporated in automatic environmental 
speed vac system (Savant, Instruments, Inc. Farmingdale, NY) then reconstituted in 
equal volume of cell culture medium. Human umbilical vein endothelial cells 
(HUVECs) obtained from ATCC, Manassas (VA, USA) (3 x 106) were incubated with 5 
or 10 µl of C18-DOM and with 0.3mM of aspirin as control for 12 h [17]. Expression of 
HO-1 was measured by western blotting with anti-HO-1 mouse monoclonal Ab (1:2000, 
Stressgen Biotechnology). 
 
NMR spectroscopy. C18-DOM was subjected to 1H, 13C-NMR spectroscopy (Bruker 
Biospin Avance 400, Ehime Techno Research Center). The ethanol in C18-DOM was 
evaporated to dryness and reconstituted in MeOD, at 25ºC. The reference for 1H-NMR 
was tetra methyl silane (4.699 ppm, 400.13MHz), and for 13C-NMR tetra methyl silane 
(100.1MHz) was used. 
 
ESI/ TOF/ Mass spectrometry (MS). C18-DOM was subjected to ESI-TOF-MS (Applied 
Biosystem Q-STAR XL). The eluant used is H2O/methanol (1/1) + 0.1% formic acid 
(positive), H2O / methanol (1/1) + 5 mM acetic acid ammonium (negative). The 
references used were reserpine, dimethylacetamide (positive) and taurocholic acid 
(negative). 
 
Preparation of the biosensor chip. Cyclooxygenase-1 (Cayman Chemical, MI, USA) 
was immobilized (yielding approximately 9000 relative response [RU]) on the surface 
of a CM5 sensor chip by using an amine coupling kit, following the manufacturer's 
instructions [18]. The sensor chip surface was washed repeatedly with 50 mM NaOH 
for 1 min at a flow rate of 60 μl/min. 
 
BIACORE for C18-DOM. Mixing of all the reagents, injection, and washing were 
performed manually by the Biacore J. The running buffer was HBS-N buffer (10mM 
HEPES/0.15M NaCl, pH7.4) at a flow rate of 20 μl/min. Ethanol in C18-DOM was 
evaporated, then reconstituted in equal volume of HBS-N buffer and filtered through 0.2 
μm Millex filter. The mixture was injected for 3 min over the immobilized surface and 
the reference (non-immobilized) surface. The surface was regenerated with 25 mM 
NaOH for 1 min at a flow rate of 60 μl/min. The total run time between the samples was 
about 2 min. RUs were recorded on each sensor gram 15 s after the injection. All RU 
values were corrected by subtraction of the RUs from the reference surfaces.  
 
Statistical analysis. Data were expressed as mean ± S.E.M. Differences between means 
were examined by paired Students t-test and p < 0.05 were regarded as being 
statistically significant. 
 
Results  
C18-DOM inhibits the progression of neointimal hyperplasia  
In balloon-injured RCCAs, the ratio of neointima versus media is significantly reduced 
in C18-DOM treated group (0.08 ± 0.05 versus 1.86 ± 0.50, C18-DOM fed versus 
controls, p < 0.05) and also in 1% DSW (v/v) group (0.32 ± 0.14 versus 1.86 ± 0.50, 1% 
DSW fed versus controls, p < 0.05) (Fig.1A and B). In contrast there is no significant 
reduction in the ratio of neointima versus media in Inorg-DSW fed group, which 
suggests that the anti-atherosclerotic effect is derived specifically from the organic 
components of seawater. Moreover our results that the surface water does not have 
anti-atherosclerotic effect, implies that only DOM existing below the surface ocean may 
have the effects. 
C18-DOM inhibits platelet aggregation  
In C18-DOM fed group showed significant decrease in platelet aggregation value in 2 
weeks compared to pre value when stimulated by 40 µM of ADP (32.7 ± 5.0 versus 
46.4 ± 3.3, 2 week value versus pre value, p < 0.05). Moreover, C18-DOM fed group 
showed significant decrease in platelet aggregation value in 2 weeks compared to pre 
value when stimulated by 0.2µg / ml of collagen (45.2 ± 3.3 versus 69.2 ± 3.0, 2 week 
value versus pre value, p < 0.01) (Fig. 2a). 1% DSW (v/v) fed group showed significant 
decrease in platelet aggregation value (% of change in light transmittance) in 2 weeks 
compared to pre value when stimulated by 10 µM of ADP (27.0 ± 4.3 versus 38.5 ± 3.0, 
2 week value versus pre value, p < 0.05) (Fig. 2b). In contrast, Inorg-DSW has no effect 
on the platelet aggregation (Fig. 2c). 
Cholesterol profile in rabbits 
Although C18-DOM inhibited the development of neointimal thickness, platelet 
aggregation, total cholesterol levels were not reduced. After 4 weeks, the total 
cholesterol level increased from 32.67±14.92 mg/dl to 424.74 ± 36.24 mg/dl in the 
control group and from 50.76 ± 9.16 mg/dl to 445.40 ± 87.28 mg/dl in the C18-DOM 
group. The differences between the 2 groups at both the starting (p = 0.17 vs. control) 
and end point (p = 0.41 vs. control) were not significantly different (Table.1)  
Aspirin like effects of C18-DOM  
In addition to our in vivo studies, we analysed the effect of C18-DOM on the expression 
of platelet adhesion molecule named P-selectin upon stimulation by 20 µM of ADP. 
C18-DOM markedly attenuated the P-selectin expression (Fig.3A). To investigate the 
effect of C18-DOM, we performed COX inhibitor screening assay with aspirin as 
reference and measured the production of PGF2α. C18-DOM inhibited the activity of 
COX-1 significantly when compared to vehicle group in a dose dependent manner (Fig. 
3B). Our western blot analyses showed that C18-DOM induces the expression of HO-1 
in human umbilical vein endothelial cells (HUVECs) in a dose dependent manner with a 
feature similar to that of aspirin (Fig. 3C).  
Further, we conducted chemical characterization of C18-DOM using NMR technique. 
The results obtained were consistent with Hertkorn, et al (Supplemental Data 1) [19]. 
Moreover our ESI/ TOF/ Mass Spectrometry (MS) analysis showed that C18-DOM is 
composed of molecules with molecular weight ranging from 220 to 1000 amu with peak 
occurring around 400 amu (data not shown).  
 
Binding pattern of C18-DOM to immobilized COX-1 on sensor chip 
 
COX-1 was immobilized onto the surface of a CM5 sensor chip. Significant difference 
in response unit (RU = 9000) was observed in the sensor gram prior to immobilization 
and post deactivation, reflecting a successful immobilization of COX-1 onto the sensor 
surface. The Resonance Unit (RU) indicated the bound mass on sensor surface with 
time. The functionalised CM5 chip was evaluated for its ability to detect the binding 
capacity of molecules in C18-DOM with COX-1. C18-DOM binds to the COX-1 
yielding a maximum strength at flow rates of 100 µl/min with an effect similar to 
aspirin (Fig.4).   
 
Discussion  
 
Deep seawater (DSW) designates the water, which flows below 1000 meters from 
the surface of the sea [20]. Our previous studies in healthy human volunteers showed 
that desalted DSW intake inhibited the platelet aggregation significantly with p < 0.01 
(data not shown). However, the knowledge about the biologically active substances, 
which is responsible for the above-mentioned effect, is still unclear.  
Dissolved organic matter (DOM) is the largest reservoir of reduced carbon in the 
oceans. The amount of carbon in oceanic DOM (~700 x 1015 g) is similar to that of 
atmospheric carbon, which has raised interest in the DOM pool in global carbon cycle 
research [21]. The production of DOM includes extra cellular release by phytoplankton, 
grazer mediated release, excretion release via cell lyses (both viral and bacterial) & 
solubilization of particles and bacterial transformation and release [22], [23], [24], [25] 
and [26]. In contrast with surface DOM, much of the DOM in the deep ocean is quite 
resistant to microbial degradation, photo oxidation and has an average radiocarbon age 
of several millennia [27] and [28]. Efforts to improve methods for isolation and 
characterization continued as a major research area in the 1980s, with an emphasis on 
NMR methods [29]. DOM has various functions and plays important roles in chemical, 
biological and even physical oceanography [30].  
Recently, activated platelets have not only been implicated in thrombosis but also 
in inflammatory reactions, immune responses, and in distinct aspects of atherosclrerosis. 
Importantly, an intermittent injection of activated platelets has been shown to 
exacerbate the formation of native atherosclerotic lesions, a process involving platelet 
surface receptors that facilitate mononuclear cell recruitment. By similar mechanisms, 
platelet adhesion to subendothelial smooth muscle cells has been shown to increase 
MCP-1 secretion by SMCs, as well as their migratory properties, which appears to be 
particularly relevant in the context of arterial injury and restenosis. Activated platelets 
exacerbate atherosclerosis in apoE-/-mice in a P-selectin dependent manner [6], [7], [8], 
[9], [10], [11] &[12]. 
Aspirin is a cyclooxygenase-1 (COX-1) inhibitor, thus inhibiting the prostaglandin 
release, which is a mediator of inflammation, platelet aggregation, etc. Previous studies 
showed that high dose of aspirin (12mg/kg/day) significantly inhibited the 
neointima/media ratio in balloon injured iliac artery compared to control group, 
although it has no effect on cholesterol level of rabbits. But the most important side 
effect of high dose is aspirin resistance in the treatment of atherosclerosis. These side 
effects limit administration of aspirin in the treatment of atherosclerosis [31].  
 
It has been reported that heme oxygenase-1 (HO-1) exerts anti-atherosclerotic 
effects in different animal models. Hence HO-1 is considered to be a novel therapeutic 
approach to treat atherosclerosis [32], [33] and [34]. Previous reports showed that 
aspirin induces the expression of HO-1in endothelial cells by NO dependent pathway 
[17]. 
 
This is the first study showing the anti-atherosclerotic effects of DOM from DSW. 
DOM attenuated the neointimal hyperplasia in balloon injured RCCAs, platelet 
aggregation, P-selectin expression and COX-1 activity. Considering the results of NMR 
analysis, ESI/TOF/MS analysis and that of the animal and other in vitro experiments, 
we could hypothesize that some compound of marine origin possessing active 
functional groups similar to aspirin might be present in C18-DOM, moreover 
C18-DOM consists of many different molecules further analysis should be done to 
differentiate the antiatherosclerotic activity from that of aspirin. 
 
Acknowledgements 
We thank the Deep seawater drawing system, Kochi prefecture, Japan for providing us 
the original seawater, surface seawater, 1% DSW (v/v) and Inorg-DSW.  
 
References 
[1]   A.J. Lusis. Atherosclerosis. Nature 407 (2000) 233-241.  
[2]  T.F. Molinski and P.A. Searle. Phorboxazoles A and B: Potent cytostatic 
macrolides from marine sponge phorbas sp, J. Am. Chem. Soc. 117 (1995) 
8126-8131. 
[3]   D.R. Williams, A.A. Kiryanov, U. Emde, M.P. Clark, M.A. Berliner and J.T. 
Reeves. Studies of stereocontrolled allylation reactions for the total synthesis of 
phorboxazole A, Proceedings of the National Academy of Sciences 101 (2004)  
12058-12063. 
[4]   J. Antonio and T.F. Molinski. Screening of marine invertebrates for the presence 
of ergosterol-sensitive antifungal compounds. J. Nat. Prod. 56 (1993) 54-61. 
[5]   J. Gafni, J.A. Munsch, T.H. Lam, M.C. Catlin, L.G. Costa, T.F. Molinski and I.N. 
Pessah. Xestospongins: Potent membrane permeable blockers of the inositol 1, 4, 
5-triphosphate receptor. Neuron 19 (1997) 723-733. 
[6]   W. Christian. Platelets and chemokines in atherosclerosis: Partners in crime. Circ. 
Res. 96 (2005) 612-616.  
[7]   S. Willoughby, A. Holmes, J. Loscalzo. Platelets and cardiovascular disease.   
Eur. J Cardiovasc Nur. 1 (2002) 273-288.  
[8]   Z.M. Dong, S.M. Chapman, A.A. Brown, P.S. Frenette, R.O. Hynes and D.D. 
Wagner. The combined role of P- and E- selectins in atherosclerosis. J. Clin. 
Invest. 102 (1998) 145-152.  
[9]   G. Davi, C. Patrono. Platelet activation and atherothrombosis. N. Engl. J. Med. 
357 (2007) 2482-2494. 
[10]  O. Belton, Fitzgerald DJ. Cyclooxygenase isoforms and atherosclerosis. Expert 
Reviews in molecular Medicine 5 (2003) 1-18.  
[11]  G. Gaetano, M.B. Donati, C. Cerletti. Prevention of thrombosis and vascular 
inflammation: benefits and limitations of selective or combined COX-1, COX-2 
and 5-LOX inhibitors. Trends in Pharmacological Sciences 24 (2003) 245-252.  
[12]   F. Catella Lawson. Cyclooxygenase inhibitors and the antiplatelet effects of    
aspirin. N. Engl. J. Med. 346 (2002) 1589-1590.  
[13]  Q. Xu. Mouse models of arteriosclerosis. Am. J. Pathol. 165 (2004) 1-10.  
[14]  F.J. Rosenberg, P.E. Gimber-Philips, G.E. Groblewski, C. Davison, D.K. Philips, 
S.J. Goralnick, Cahill ED. Acetyl salicylic acid: Inhibition of platelet 
aggregation in the rabbit. J. Pharmacol. Exper. Thera. 179 (1971) 410-418.  
[15]  K. Daub, H. Langer, Seizer P, Stellos K, May A, Goyal P, Bigalke B, 
Schonberger T, Geisor T, Seigel-Axel D, Oostendorp RJ, Linderman S, Gawaz 
M. Platelets induce differentiation of human CD34+ progenitor cells into foam 
cells and endothelial cells. The FASEB Journal 20 (2006) E1935-1944. 
[16]   T. Noguchi, R. Shimazawa, K. Nagasawa, Y. Hashimoto. Thalidomide and its 
analogues as cyclooxygenase inhibitors. Bioorganic & Medicinal Chemistry 
Letters 12 (2002) 1043-1046.  
[17]   N. Grosser, A. Abate, Oberle S, Vreman HJ, Dennery PA, Becker JC, Pohle T, 
Seidman DS, Schroder H. Heme oxygenase-1 induction may explain the 
antioxidant profile of aspirin. Biochem Biophysic Res Commun. 308 (2003) 
956-960. 
[18]   T. Tsutsumi, N. Miyoshi, Sasaki K, Maitani T. Biosensor immunoassay for the 
screening of dioxin-like polychlorinated biphenyls in retail fish. Analytica. 
Chimica. Acta. 617 (2008) 177-183. 
[19]   N. Hertkorn, R. Benner, M. Frommberger, P. Schmitt-Kopplin, M. Witt, Kaiser 
K, Kettrup A, Hedges JI. Characterization of a major refractory component of 
marine dissolved organic matter. Geochim. Cosmochim. Acta. 70 (2006) 
2990-3010. 
[20]   W.S. Broecker. The great ocean conveyor. Oceanography 4 (1991) 79-89. 
[21]   R. Benner, J. D Pakulski, M. McCarthy, Hedges JI, Hatcher. PG. Bulk chemical 
characteristics of dissolved organic matter in the ocean. Science 255(1992) 
1561-1564.   
[22]   M. McCarthy, J.I. Hedges, R. Benner. Major bacterial contribution to marine     
dissolved organic nitrogen. Science 281 (1998) 231-234.  
[23]   E. Tanoue, S. Nishiyama, M. Kamo, A. Tsugita. Bacterial membranes: Possible 
source of a major dissolved protein in seawater. Geochim. Cosmochim. Acta. 59 
(1995) 2643-2648.  
[24]   C.A. Carlson. Biogeochemistry of Marine Dissolved Organic Matter  (ed, 
Hansell, D. A & Carlson, C. A.)  91-151. (Academic press, London, UK, 2002)  
[25]   M.A. Wilson, A.H. Gilliam, P.J. Collins. Analysis of the structure of dissolved 
marine humic substances and their phytoplanktonic precursors by 1H and 13C 
nuclear magnetic resonance. Chem. Geol. 40 (1983) 187-201.  
[26]   W.C. Chin, M.V. Orellana, P. Verdugo. Spontaneous assembly of marine 
dissolved organic matter into polymer gels. Nature 391(1998) 568-570.  
[27]   H. Ogawa, Y. Amagai, I. Koike, K. Kaiser, R. Benner. Production of refractory 
dissolved organic matter by bacteria. Science 292 (2001) 917-920.  
[28]   R.T. Barber. Dissolved organic carbon from deep waters resists microbial 
oxidation. Nature 220 (1968) 274-275.  
[29]  D.F. Gruber, J-P Simjouw, S.P. Seitzinger, G.L. Taghon. Dynamics and    
characterization of refractory dissolved organic matter produced by a pure 
bacterial culture in an experimental predator-prey system. Appl. Environ. 
Microbiol. 72 (2006) 4184-4191.  
[30]   H. Ogawa, E. Tanoue. Dissolved organic matter in oceanic waters. J. Oceanogr. 
59 (2003) 129-147.  
[31]  M. Li, Y Zhang, H Ren, Y Zhang, X Zhu. Effect of clopidogrel on the 
inflammatory progression of early atherosclerosis in rabbit model. 
Atherosclerosis 194 (2007) 348-356. 
[32]   T. Morita. Heme oxygenase and atherosclerosis. Arterioscler. Thromb. Vas. Biol. 
25 (2005) 1786-1795.  
[33]   K. Ishikawa, D. Sugawara, J. Goto, Y. Watanabe, K. Kawamura, M. Shiomi, H. 
Itabe, Y Maruyama. Heme oxygenase-1 inhibits atherogenesis in watanabe 
heritable hyperlipidemic rabbits. Circulation 104 (2001) 1831-1836.  
[34]   R.C. Siow M, H. Sato, G.E. Mann. Heme oxygenase-Carbon monoxide 
signaling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and 
carbon monoxide? Cardiovas. Res. 41 (1999) 385-394. 
 
Figure Legends 
Fig. 1. C18-DOM attenuates the neointimal hyperplasia in balloon injured common 
carotid arteries of JMWRs. (A) depicts the photomicrographs of Von Gieson elastic 
lamina staining of balloon injured RCCAs in distilled water (a), surface SW (b), Inorg 
DSW (c), 1% DSW (v/v) (d) and C18-DOM (e) fed groups’. Scale bar, 200 µm (n = 6). 
(B) the graph represents the ratio of neointima vs. media in various groups. Data are 
presented as an average for each group. Error bars indicate standard error of the mean ± 
SEM.  
 
Fig. 2. (a) Shows that C18-DOM significantly inhibited collagen-induced (0.2 µg/ml) 
PA with **p < 0.01. (b) 1% DSW (v/v) significantly inhibited the ADP-induced (20 
µM) platelet aggregation with *p < 0.05. (c) In contrast, Inorg-DSW had no effect on 
the platelet aggregation of rabbit. Data are presented as an average of percentage of 
change in light transmittance (n = 6) for each group. Error bars indicate standard error 
of the mean ± SEM. Black shaded, striped, and dotted bars represent the pre, 1, 2 weeks 
platelet aggregation values respectively.  
Fig. 3. (A) C18-DOM inhibited the expression of P-selectin significantly with **p < 
0.01 when compared to vehicle group. Data are presented as mean ± SEM (error bars) 
(n = 3) of the percentage of mean fluorescence intensity compared with ADP stimulated 
platelets. (a) Vehicle group; (b) aspirin group (1mM); (c), (d) & (e), C18-DOM group 
treated platelets at 50, 500, 5000 times dilutions. Data are expressed as percentages, 
arbitrary values of 100% being attributed to the vehicle group.  
(B) C18-DOM attenuated the enzyme activity of COX-1 with **p < 0.05 when 
compared to vehicle group (unpaired t-test). Data are presented as mean ± SEM (error 
bars) (n = 3) of enzyme activity for each individual experiments. (a) Positive control (b) 
vehicle (5% ethanol), (c) 100 µM of aspirin, (d, e, & f) 50, 500, 5000 times dilution of 
C18-DOM. PG: prostaglandin.  
(C) Western blotting analysis shows the HO-1 expression in HUVECs. Panels a & b 
show the expression of HO-1 by 5 or 10 µl of C18-DOM. Panel c shows the expression 
of HO-1 by 0.3 mM of aspirin. 
 
Fig. 4. Evaluation of C18-DOM on immobilized COX-1. 
 (A) Shows coupling of COX-1 enzyme on CM5 sensor chip. (B) Evaluation of 
binding of aspirin (5 mM) on immobilized COX-1. (C) Evaluation of binding of 
C18-DOM on immobilized COX-1 on the CM5 sensor chip. C18-DOM binding with 
COX-1 was observed an effect similar to 5mM of aspirin.  
Table 1  
Table shows the total and LDL cholesterol levels in 3 groups both at the start of the 
experiment and after 4 weeks. After 4 weeks, the total cholesterol level increased from 
32.67±14.92 mg/dl to 424.74 ± 36.24 mg/dl in the control group and from 50.76 ± 9.16 
mg/dl to 445.40 ± 87.28 mg/dl in the C18-DOM group. The differences between the 2 
groups at both the starting (p = 0.17 vs. control) and end point (p = 0.41 vs. control) 
were not significantly different.   
 
T-CHO (mg/dl) LDL-CHO (mg/dl) 
Groups (Gp) Pre Post Pre Post 
Control Gp 32.6 ± 14.9 424.7 ± 36.2 15.1 ± 8.6 93.8 ± 3.6 
1% DSW Gp 44.0 ± 13.3 945.6 ± 107.5 22.9 ± 7.9 187.0 ± 23.0 
C18-DOM Gp 50.7 ± 9.1 445.4 ± 87.2 28.8 ± 6.9 76.2 ± 14.7 
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